angioedema
Information
- Disease name
- angioedema
- Disease ID
- DOID:1558
- Description
- "A skin disease characterized by one or more areas of well-demarcated, non-pitting edema of deep subcutaneous tissues." [url:http\://en.wikipedia.org/wiki/Angioedema, url:https\://www.ncbi.nlm.nih.gov/books/NBK430889/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00004694 | Completed | N/A | Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations | January 1994 | September 1998 |
| NCT00097695 | Completed | Phase 3 | Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema | December 28, 2004 | July 17, 2006 |
| NCT00125151 | Completed | Phase 3 | C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema | February 2006 | April 2007 |
| NCT00125541 | Completed | Phase 2/Phase 3 | C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema | November 2006 | May 2008 |
| NCT00876369 | Completed | Vitamin D Levels in Subjects With Chronic Urticaria and Angioedema | September 1, 2009 | December 11, 2009 | |
| NCT00890162 | Completed | Phase 2 | A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis | April 27, 2009 | May 31, 2019 |
| NCT01154361 | Completed | Phase 2 | AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study | ||
| NCT01371877 | Completed | N/A | The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment | November 1, 2011 | September 1, 2013 |
| NCT01723072 | Completed | Phase 3 | Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy | January 23, 2013 | May 9, 2014 |
| NCT02833675 | Completed | Determination of Specific Biomarkers of Angioneurotic Crisis | October 2012 | September 2017 | |
| NCT03240991 | Completed | Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK) | July 11, 2016 | December 1, 2016 | |
| NCT04206605 | Completed | Phase 3 | A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) | May 4, 2020 | October 20, 2022 |
| NCT04444895 | Completed | Phase 3 | A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor | February 5, 2021 | May 5, 2023 |
| NCT06096077 | Completed | Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department | November 30, 2022 | August 23, 2023 | |
| NCT00385372 | Completed | N/A | Significance of an Elimination and Provocation Diet in Patients With Chronic Urticaria | January 2005 | April 2007 |
| NCT04583007 | No longer available | Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults | |||
| NCT06210698 | Not yet recruiting | Angioedema Biomarker Research Study | January 15, 2024 | February 1, 2026 | |
| NCT05936567 | Recruiting | Phase 2 | Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria | July 31, 2023 | September 5, 2025 |
| NCT04334031 | Recruiting | N/A | Deployment o the Multidisciplinary Prospective Cohort Imminent | July 20, 2020 | July 2031 |
| NCT05578417 | Recruiting | A Study to Review the Treatment and Outcomes of Teenagers and Adults With Non-histaminergic Angioedema With Normal C1 Inhibitor in Canada | June 15, 2023 | June 30, 2024 | |
| NCT03845946 | Recruiting | CLOUD-R HAE REGISTRY | September 1, 2018 | September 1, 2028 | |
| NCT04597944 | Recruiting | Lanadelumab in Bradykinin Angioedema | September 18, 2020 | September 2025 | |
| NCT04128371 | Terminated | Phase 2 | Mepolizumab in Episodic Angioedema With Eosinophilia | January 14, 2021 | October 31, 2022 |
| NCT00163839 | Unknown status | N/A | The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema | September 2005 | |
| NCT01036659 | Unknown status | Phase 2 | Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema | May 2010 | December 2013 |
- Disase is a (Disease Ontology)
- DOID:37
- Cross Reference ID (Disease Ontology)
- ICD10CM:T78.3
- Cross Reference ID (Disease Ontology)
- MESH:D000799
- Cross Reference ID (Disease Ontology)
- NCI:C112175
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:41291007
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0002994
- Exact Synonym (Disease Ontology)
- angioneurotic edema
- Exact Synonym (Disease Ontology)
- Angioneurotic oedema
- Exact Synonym (Disease Ontology)
- giant urticaria
- Exact Synonym (Disease Ontology)
- Quincke's edema
- HPO alt_id (Human Phenotype Ontology)
- HP:0100666
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0100665
- MeSH unique ID (MeSH (Medical Subject Headings))
- D000799